Logo image of EGBN

EAGLE BANCORP INC (EGBN) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:EGBN - US2689481065 - Common Stock

27.88 USD
+3.85 (+16.02%)
Last: 1/22/2026, 8:00:01 PM
27.88 USD
0 (0%)
After Hours: 1/22/2026, 8:00:01 PM
Fundamental Rating

2

EGBN gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 383 industry peers in the Banks industry. Both the profitability and financial health of EGBN have multiple concerns. EGBN has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year EGBN has reported negative net income.
  • In the past year EGBN had a positive cash flow from operations.
  • In multiple years EGBN reported negative net income over the last 5 years.
  • Of the past 5 years EGBN 4 years had a positive operating cash flow.
EGBN Yearly Net Income VS EBIT VS OCF VS FCFEGBN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -1.12%, EGBN is doing worse than 94.52% of the companies in the same industry.
  • EGBN has a worse Return On Equity (-10.74%) than 94.26% of its industry peers.
Industry RankSector Rank
ROA -1.12%
ROE -10.74%
ROIC N/A
ROA(3y)0.57%
ROA(5y)0.88%
ROE(3y)5.18%
ROE(5y)7.85%
ROIC(3y)N/A
ROIC(5y)N/A
EGBN Yearly ROA, ROE, ROICEGBN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10

1.3 Margins

  • EGBN does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EGBN Yearly Profit, Operating, Gross MarginsEGBN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

2

2. Health

2.1 Basic Checks

  • EGBN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • EGBN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
EGBN Yearly Shares OutstandingEGBN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
EGBN Yearly Total Debt VS Total AssetsEGBN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

  • EGBN has a debt to FCF ratio of 2.29. This is a good value and a sign of high solvency as EGBN would need 2.29 years to pay back of all of its debts.
  • EGBN has a Debt to FCF ratio of 2.29. This is comparable to the rest of the industry: EGBN outperforms 43.60% of its industry peers.
  • EGBN has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
  • With a decent Debt to Equity ratio value of 0.08, EGBN is doing good in the industry, outperforming 72.85% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 2.29
Altman-Z N/A
ROIC/WACCN/A
WACC17.95%
EGBN Yearly LT Debt VS Equity VS FCFEGBN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
EGBN Yearly Current Assets VS Current LiabilitesEGBN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2

3. Growth

3.1 Past

  • The earnings per share for EGBN have decreased strongly by -323.94% in the last year.
EPS 1Y (TTM)-323.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-50%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%25.14%

3.2 Future

  • Based on estimates for the next years, EGBN will show a very strong growth in Earnings Per Share. The EPS will grow by 62.11% on average per year.
  • Based on estimates for the next years, EGBN will show a small growth in Revenue. The Revenue will grow by 3.37% on average per year.
EPS Next Y137.92%
EPS Next 2Y62.11%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year0.83%
Revenue Next 2Y3.37%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

EGBN Yearly Revenue VS EstimatesEGBN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
EGBN Yearly EPS VS EstimatesEGBN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 4 -4

2

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for EGBN. In the last year negative earnings were reported.
  • EGBN is valuated rather expensively with a Price/Forward Earnings ratio of 17.46.
  • Based on the Price/Forward Earnings ratio, EGBN is valued a bit more expensive than 73.37% of the companies in the same industry.
  • EGBN's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 24.32.
Industry RankSector Rank
PE N/A
Fwd PE 17.46
EGBN Price Earnings VS Forward Price EarningsEGBN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

  • 69.45% of the companies in the same industry are cheaper than EGBN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 21.5
EV/EBITDA N/A
EGBN Per share dataEGBN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as EGBN's earnings are expected to grow with 62.11% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y62.11%
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

  • EGBN has a yearly dividend return of 0.18%, which is pretty low.
  • With a Dividend Yield of 0.18, EGBN pays less dividend than the industry average, which is at 2.84. 87.21% of the companies listed in the same industry pay a better dividend than EGBN!
  • With a Dividend Yield of 0.18, EGBN pays less dividend than the S&P500 average, which is at 1.83.
Industry RankSector Rank
Dividend Yield 0.18%

5.2 History

  • On average, the dividend of EGBN grows each year by 17.91%, which is quite nice.
  • EGBN has been paying a dividend for at least 10 years, so it has a reliable track record.
  • As EGBN did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)17.91%
Div Incr Years5
Div Non Decr Years5
EGBN Yearly Dividends per shareEGBN Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

  • EGBN has negative earnings and hence a negative payout ratio. The dividend may be in danger.
  • The dividend of EGBN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-16.59%
EPS Next 2Y62.11%
EPS Next 3YN/A
EGBN Yearly Income VS Free CF VS DividendEGBN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

EAGLE BANCORP INC

NASDAQ:EGBN (1/22/2026, 8:00:01 PM)

After market: 27.88 0 (0%)

27.88

+3.85 (+16.02%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)01-21
Earnings (Next)04-21
Inst Owners82.91%
Inst Owner Change0.01%
Ins Owners7.57%
Ins Owner Change-0.35%
Market Cap846.72M
Revenue(TTM)N/A
Net Income(TTM)-120.61M
Analysts78
Price Target21.29 (-23.64%)
Short Float %10.97%
Short Ratio7.05
Dividend
Industry RankSector Rank
Dividend Yield 0.18%
Yearly Dividend1.52
Dividend Growth(5Y)17.91%
DP-16.59%
Div Incr Years5
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-1039.2%
Min EPS beat(2)-1462.99%
Max EPS beat(2)-615.41%
EPS beat(4)1
Avg EPS beat(4)-541.55%
Min EPS beat(4)-1462.99%
Max EPS beat(4)0.04%
EPS beat(8)3
Avg EPS beat(8)-269.53%
EPS beat(12)6
Avg EPS beat(12)-176.42%
EPS beat(16)8
Avg EPS beat(16)-132.24%
Revenue beat(2)0
Avg Revenue beat(2)-6.21%
Min Revenue beat(2)-7.31%
Max Revenue beat(2)-5.1%
Revenue beat(4)0
Avg Revenue beat(4)-9.16%
Min Revenue beat(4)-13.86%
Max Revenue beat(4)-5.1%
Revenue beat(8)1
Avg Revenue beat(8)-6.08%
Revenue beat(12)3
Avg Revenue beat(12)-4.47%
Revenue beat(16)7
Avg Revenue beat(16)-2.17%
PT rev (1m)5.03%
PT rev (3m)4.05%
EPS NQ rev (1m)-31.73%
EPS NQ rev (3m)-71100%
EPS NY rev (1m)0%
EPS NY rev (3m)-54.9%
Revenue NQ rev (1m)-1.49%
Revenue NQ rev (3m)-9.6%
Revenue NY rev (1m)-0.67%
Revenue NY rev (3m)-5.41%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 17.46
P/S 2.88
P/FCF 21.5
P/OCF 19.07
P/B 0.75
P/tB 0.75
EV/EBITDA N/A
EPS(TTM)-4.21
EYN/A
EPS(NY)1.6
Fwd EY5.73%
FCF(TTM)1.3
FCFY4.65%
OCF(TTM)1.46
OCFY5.25%
SpS9.67
BVpS36.99
TBVpS36.99
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.12%
ROE -10.74%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM 13.41%
ROA(3y)0.57%
ROA(5y)0.88%
ROE(3y)5.18%
ROE(5y)7.85%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 2.29
Debt/EBITDA N/A
Cap/Depr 150.16%
Cap/Sales 1.71%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score3
WACC17.95%
ROIC/WACCN/A
Cap/Depr(3y)25.28%
Cap/Depr(5y)45.47%
Cap/Sales(3y)0.24%
Cap/Sales(5y)0.59%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-323.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-50%
EPS Next Y137.92%
EPS Next 2Y62.11%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%25.14%
Revenue Next Year0.83%
Revenue Next 2Y3.37%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-79.64%
FCF growth 3Y-19.09%
FCF growth 5Y-1.01%
OCF growth 1Y-77.14%
OCF growth 3Y-19.63%
OCF growth 5Y-1.38%

EAGLE BANCORP INC / EGBN FAQ

What is the fundamental rating for EGBN stock?

ChartMill assigns a fundamental rating of 2 / 10 to EGBN.


Can you provide the valuation status for EAGLE BANCORP INC?

ChartMill assigns a valuation rating of 2 / 10 to EAGLE BANCORP INC (EGBN). This can be considered as Overvalued.


Can you provide the profitability details for EAGLE BANCORP INC?

EAGLE BANCORP INC (EGBN) has a profitability rating of 1 / 10.


Can you provide the financial health for EGBN stock?

The financial health rating of EAGLE BANCORP INC (EGBN) is 2 / 10.


What is the earnings growth outlook for EAGLE BANCORP INC?

The Earnings per Share (EPS) of EAGLE BANCORP INC (EGBN) is expected to grow by 137.92% in the next year.